Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site

Andrew T. Carter; David R. Mason; Kathie A. Grant; Giovanna Franciosa; Paulo Aureli; Michael W. Peck

doi:10.1128/JCM.01774-09

Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site

Andrew T. Carter
, David R. Mason
, Kathie A. Grant
, Giovanna Franciosa
, Paulo Aureli
, Michael W. Peck

Research output: Contribution to journal › Letter › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	1012-1013
Number of pages	2
Journal	Journal of Clinical Microbiology
Volume	48
Issue number	3
DOIs	https://doi.org/10.1128/JCM.01774-09
Publication status	Published - Mar 2010

Access to Document

10.1128/JCM.01774-09

Cite this

@article{919d9e5758f34601b505c617d7b318a4,

title = "Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site",

author = "Carter, \{Andrew T.\} and Mason, \{David R.\} and Grant, \{Kathie A.\} and Giovanna Franciosa and Paulo Aureli and Peck, \{Michael W.\}",

year = "2010",

month = mar,

doi = "10.1128/JCM.01774-09",

language = "English",

volume = "48",

pages = "1012--1013",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "3",

}

Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site. / Carter, Andrew T.; Mason, David R.; Grant, Kathie A. et al.
In: Journal of Clinical Microbiology, Vol. 48, No. 3, 03.2010, p. 1012-1013.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site

AU - Carter, Andrew T.

AU - Mason, David R.

AU - Grant, Kathie A.

AU - Franciosa, Giovanna

AU - Aureli, Paulo

AU - Peck, Michael W.

PY - 2010/3

Y1 - 2010/3

UR - https://www.scopus.com/pages/publications/77749320954

U2 - 10.1128/JCM.01774-09

DO - 10.1128/JCM.01774-09

M3 - Letter

C2 - 20042627

AN - SCOPUS:77749320954

SN - 0095-1137

VL - 48

SP - 1012

EP - 1013

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 3

ER -

Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site

Access to Document

Other files and links

Cite this